Macca, I think this data is potentially very important to Immutep.....
Data driven evidence of "Efti" and it's compatibility and efficacy
with Keytruda should not be underestimated......Efficacy, I know
is a bit off but compatibility is right here, right now......Merck has
already shown an interest leading to action in the form of supply
of keytruda for Immutep instigated combination trials......
Don't underestimate the SITC news.....
Ann: Operational Update, page-15
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
